Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Improved survival of severe combined immunodeficiency (scid) mice with cryptosporidiosis by adoptively transferring CD4+ and CD4- CD8- B220- BALB/c splenocytes (Spls).

Kuhls TL, Mosier DA, Crawford DL, Abrams VL, Greenfield RA.

J Eukaryot Microbiol. 1996 Sep-Oct;43(5):71S. No abstract available.

PMID:
8822867
2.

Bismuth subsalicylate prophylaxis of Cryptosporidium parvum infection in immunodeficient mice.

Greenfield RA, Mosier DA, Crawford DL, Abrams VL, Kuhls TL.

J Eukaryot Microbiol. 1996 Sep-Oct;43(5):69S. No abstract available.

PMID:
8822865
3.

Enteral human serum immunoglobulin treatment of cryptosporidiosis in mice with severe combined immunodeficiency.

Kuhls TL, Orlicek SL, Mosier DA, Crawford DL, Abrams VL, Greenfield RA.

Infect Immun. 1995 Sep;63(9):3582-6.

4.

Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency.

Kuhls TL, Mosier DA, Abrams VL, Crawford DL, Greenfield RA.

J Parasitol. 1994 Jun;80(3):480-5.

PMID:
7515109
5.

Therapy with atovaquone for Cryptosporidium parvum infection in neonatal severe combined immunodeficiency mice.

Rohlman VC, Kuhls TL, Mosier DA, Crawford DL, Hawkins DR, Abrams VL, Greenfield RA.

J Infect Dis. 1993 Jul;168(1):258-60. No abstract available.

PMID:
8515130
6.

Supplemental Content

Loading ...
Support Center